2
Oct 2026
Tirzepatide cuts fat mass by 35% while preserving skeletal muscle
Tirzepatide cuts body fat while preserving skeletal muscle in real-world study

Innovators and start-ups in healthcare and biotech are experts in their innovation’s scientific and technical domain but often struggle with navigating the complex world of the healthcare industry.
If you want to objectively show the advantages and competitiveness of your innovation to potential investors, future users, (reimbursement) payers or even the media, you can greatly benefit from Mercury Pharmaceuticals’s Health Innovation Assessment solution.
By making use of robust methods to collect and analyse data, Health Innovation Assessment (HIA) aims to comprehensively assess the added value of (bio-)medical and healthcare innovations. HIA takes into account true multi-stakeholder perspectives on value assessment and the realm of marketplace decision making.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
2
Oct 2026
Tirzepatide cuts body fat while preserving skeletal muscle in real-world study
2
Oct 2026
Daily walnuts improve mood and alter serotonin-related metabolites in young adults.
2
Oct 2026
Gut bacteria may prime immune cells to worsen stroke damage
2
Oct 2026
Across hundreds of societies, researchers traced how marriage payments, inheritance, and family structure intersect with one of religion’s most enduring evolutionary puzzles.